NCT01590732 2018-09-19Romidepsin, Ifosfamide, Carboplatin, and Etoposide in Treating Participants With Relapsed or Refractory Peripheral T-Cell LymphomaM.D. Anderson Cancer CenterPhase 1 Completed22 enrolled
NCT01746992 2017-11-14CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell LymphomaRuijin HospitalPhase 4 Unknown200 enrolled